ALKBH5 and neoplasm: A recent study reported that ALKBH5 regulates lactic acid and thus leads to immune resistance during ICB treatment, which suggests that epigenetic inheritance can enhance the effects of immunotherapy.242 Targeting epigenetic modification induces reprogramming of tumor metabolic processes, tumor death process, and the TME remodeling, and these effects have application prospects but also are associated with challenges.